Back

SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: a meta analysis of randomised controlled trials

1 December 2022 (08:00 - 19:00)
Organised by:
Congress Presentation Part of: Pharmacology and Pharmacotherapy Treatment ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Prachi Sharma

King George's Medical University, Lucknow (India)

2 More presentations in this session

Presentation thumbnail
Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis
Doctor R. Cordovez (Cebu City, PH)
Abstract Slides
Presentation thumbnail
Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2
Mr H. Hermawan (Surabaya, ID)
Abstract Slides

Access the full session

Session thumbnail
Pharmacology and Pharmacotherapy

The Event

Event poster

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022
You may be interested in
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
Expert panel discussion and Q&A

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources